1. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx [accessed 31.03.14.].
2. Witjes JA, Compérat E, Cowan NC, et al. Guidelines on muscle-invasive and metastatic bladder cancer. Uroweb 2013. Available from: http://www.uroweb.org/gls/pdf/07_Bladder%20Cancer_LRV2.pdf [accessed 31.03.14.].
3. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer Version 1.2014. Available from: http://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf [accessed 31.03.14.].
4. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12;Tester;Int J Radiat Oncol Biol Phys,1993
5. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group Phase II Trial 8802;Tester;J Clin Oncol,1996